Healthcare Technologies signs up European distributors:
This article was originally published in Clinica
Israeli company Healthcare Technologies has signed two European distribution deals for its diagnostics tests. The agreements, made through its Savyon diagnostics subsidiary, are with BMD in France and Hain Diagnostika in Germany. BMD has signed a five year contract, with a commitment to order $583,000 of kits in the first year, while Hain has signed-up for three years with $457,000 of orders in the first year, reports Reuters.
You may also be interested in...
Health policy changes that President-elect Joe Biden will likely make during his four-year term include Medicaid expansion and a greater reliance on medical science, among others, experts say.
Already cleared to monitor the viral load in HIV-positive individuals, the test has now been approved for initial diagnosis as well.
As with its first two approved RNAi therapies, Alnylam will negotiate value-based agreements with payers, but for Oxlumo, approved in pediatric patients, it will offer a patient need adjustment.